Targeted Coaching to Improve Osteoporosis Therapy Adherence: A Single Arm Variation of the C-STOP Study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: In this pre-planned variation of the Comparing Strategies Targeting Osteoporosis to Prevent Fractures After an Upper Extremity Fracture (C-STOP) trial, we investigated whether adherence-specific coaching by the case manager (CM) further improved the adherence and persistence rates compared to those seen in the C-STOP trial. Methods: We conducted a prospective observational cohort study of community-dwelling adults 50 years or older who suffered an upper-extremity fracture and were not previously treated with osteoporosis medications, to assess whether a well-trained CM can partner with patients to improve adherence to and persistence with oral bisphosphonate intake. The primary outcome was adherence (taking > 80% of prescribed doses) to oral bisphosphonate intake at 12 months after study enrollment. Secondary outcomes included primary adherence to and 12-month persistence with oral bisphosphonate and calcium and vitamin D supplement intake at 12 months. Results: The study cohort consisted of 84 participants, of which 30 were prescribed an oral bisphosphonate. Twenty-two (73.3%) started treatment within 3 months. The adherence rate at 12 months was 77.3%. The persistence rate at 12 months was 95.5%. Of those not prescribed an oral bisphosphonate, 62.8% were taking supplemental calcium and 93.0% were taking supplemental vitamin D at 12 months. Depression was a significant predictor of 12-month non-adherence (adjusted odds ratio, 9.8; 95% confidence interval, 1.2–81.5). Conclusions: Adherence-specific coaching by a CM did not further improve the level of medication adherence achieved in the original C-STOP study. Importantly, these results can inform adherence in future intervention studies.
Abstract
Background: In this pre-planned variation of the Comparing Strategies Targeting Osteoporosis to Prevent Fractures After an Upper Extremity Fracture (C-STOP) trial, we investigated whether adherence-specific coaching by the case manager (CM) further improved the adherence and persistence rates compared to those seen in the C-STOP trial. Methods: We conducted a prospective observational cohort study of community-dwelling adults 50 years or older who suffered an upper-extremity fracture and were not previously treated with osteoporosis medications, to assess whether a well-trained CM can partner with patients to improve adherence to and persistence with oral bisphosphonate intake. The primary outcome was adherence (taking > 80% of prescribed doses) to oral bisphosphonate intake at 12 months after study enrollment. Secondary outcomes included primary adherence to and 12-month persistence with oral bisphosphonate and calcium and vitamin D supplement intake at 12 months. Results: The study cohort consisted of 84 participants, of which 30 were prescribed an oral bisphosphonate. Twenty-two (73.3%) started treatment within 3 months. The adherence rate at 12 months was 77.3%. The persistence rate at 12 months was 95.5%. Of those not prescribed an oral bisphosphonate, 62.8% were taking supplemental calcium and 93.0% were taking supplemental vitamin D at 12 months. Depression was a significant predictor of 12-month non-adherence (adjusted odds ratio, 9.8; 95% confidence interval, 1.2–81.5). Conclusions: Adherence-specific coaching by a CM did not further improve the level of medication adherence achieved in the original C-STOP study. Importantly, these results can inform adherence in future intervention studies.
참고문헌 (19)
- "Health professionals" (2022)[URL]
- Langsetmo L, "Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD", J Bone Miner Res, 24, pp.1515~1522 (2009)[DOI]
- Kanis JA, "A meta-analysis of previous fracture and subsequent fracture risk", Bone, 35, pp.375~382 (2004)[DOI]
- Ye C, "Time since prior fracture affects mortality at the time of clinical assessment : a registry-based cohort study", Osteoporos Int, 33, pp.1257~1264 (2022)[DOI]
- Yeam CT, "A systematic review of factors affecting medication adherence among patients with osteoporosis", Osteoporos Int, 29, pp.2623~2637 (2018)[DOI]
- Koller G, "Persistence and adherence to parenteral osteoporosis therapies : a systematic review", Osteoporos Int, 31, pp.2093~2102 (2020)[DOI]
- Majumdar SR, "Comparing strategies targeting osteoporosis to prevent fractures after an upper extremity fracture(C-STOP Trial) : a randomized controlled trial", J Bone Miner Res, 33, pp.2114~2121 (2018)[DOI]
- "Edmonton" (2022)[URL]
- McAlister FA, "Adherence to osteoporosis therapy after an upper extremity fracture : a pre-specified substudy of the C-STOP randomized controlled trial", Osteoporos Int, 30, pp.127~134 (2019)[DOI]
- Papaioannou A, "2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada : summary", CMAJ, 182, pp.1864~1873 (2010)[DOI]
- Armstrong PW, "Searching for adherence : Can we fulfill the promise of evidence-based medicines?", J Am Coll Cardiol, 68, pp.802~804 (2016)[DOI]
- Cramer JA, "Medication compliance and persistence : Terminology and definitions", Value Health, 11, pp.44~47 (2008)[DOI]
- Majumdar SR, "Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture : a randomized controlled trial", CMAJ, 178, pp.569~575 (2008)[DOI]
- Majumdar SR, "Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist : results of a controlled trial", Osteoporos Int, 18, pp.261~270 (2007)[DOI]
- Wozniak LA, "Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatment", Osteoporos Int, 28, pp.219~229 (2017)[DOI]
- Sagalla N, "Extent of and reasons for osteoporosis medication non-adherence among veterans and feasibility of a pilot text message reminder intervention", Arch Osteoporos, 16, pp.21~ (2021)[DOI]
- Grenard JL, "Depression and medication adherence in the treatment of chronic diseases in the United States : a meta-analysis", J Gen Intern Med, 26, pp.1175~1182 (2011)[DOI]
- Imaz I, "Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk : systematic review and meta-analysis", Osteoporos Int, 21, pp.1943~1951 (2010)[DOI]
- Sletvold H, "Medication safety in municipal health and care services", pp.163~191 (2022), Cappelen Damm Akademisk